SOAPP-R

Purpose & Evidence:

  • Purpose: The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) predicts possible opioid abuse in chronic pain patients
  • Target population: Adults
  • Evidence:
    • Provides excellent discrimination between high risk and low risk patients (Passik et al. 2008)
    • High-risk score on the SOAPP-R correlates with an increased likelihood of drug abuse (Chou et al. 2009)
    • Study suggests that the SOAPP-R is an improvement over the original version in screening risk potential for deviant medication-related behavior among chronic pain patients (Butler et al. 2008).
  • Advantages/Limitations

    Advantages

    • SOAPP-R is cross validated (Butler et al. 2008)
    • Developed specifically for pain patients (Butler 2008)
    • Easily understood by patients, takes little time to administer and score, and taps information believed by experienced professionals to be important (Butler et al. 2008).
    • Less susceptible to overt deception than original SOAPP (Butler et al. 2008).

    Limitations

    • Less sensitive and specific than original SOAPP (Butler et al. 2008).


Test features:

  • Estimated time: 5 minutes to administer and score
  • Length: 24 items
  • Administered by: Self-Report; Observation and toxicology report by health care professional
  • Intended settings: Primary care

Copyright Inflexxion, Inc. Contact http://www.painedu.org for details/permissions.


Available Formats & Links:

Copyright Inflexxion, Inc. Contact http://www.painedu.org for details/permissions.


View ReferencesHide References
Butler SF, Fernandez K, Benoit C, et al. Validation of the Revised Screener and Opioid Assessment for Patients in Pain (SOAPP-R). J Pain. 2008; 9: 360-372.
Butler SF. Evidence of Co-occuring Alcohol and Prescription Opioid Abuse in Clinical Populations: Implications for Screening. Tufts Health Care Institute, Program on Opioid Risk Management: Conference on Co-Ingestion of Alcohol with Prescription Opioids. 2008.
Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain. 2009a; 10(2): 131-146. Available at: http://download.journals.elsevierhealth.com/pdfs/journals/1526-5900/PIIS1526590008008328.pdf Accessed on: 2013-09-12.
Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning and monitoring compliance. Pain Med. 2008; 9: S145-S166.